COVID-19 and the big pharma mess
Down to earth|June 21, 2020

COVID-19 and the big pharma mess

The pandemic has exposed a serious fault line in the global pharmaceutical supply chain, created by an industry that flourished by putting profit before public health. Amid shortage of life-saving drugs, countries now scramble for self-sufficiency. But circumventing market dynamics may not be easy